Regulatory News has published 1 story about Rhythm Pharmaceuticals on 27 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 27 September 2026.
This page is generated from Regulatory News’ editorial coverage of Rhythm Pharmaceuticals. It is not an advertisement.
On the record
- Company
- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM)
- Headquarters
- Boston, Massachusetts
- Founded
- November 2008, incorporated in Delaware
- Regulator
- Health Canada
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
